• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aradigm Corp

AQGA:GR

Ticker Delisted

Snapshot for Aradigm Corp (AQGA)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for AQGA

No chart data available.
  • AQGA:GR
  • 1M
  • 1Y
0.000
Interactive AQGA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AQGA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 0.2762
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.2200
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AQGA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AQGA

Aradigm Corporation develops novel pulmonary drug delivery systems. The Company's systems are designed to enhance the delivery and effectiveness of a number of existing and development stage drugs and reduce the need for injectable drug therapy. Aradigm's principal product development programs are based on its AERx pulmonary drug delivery system.

Igor GondaPresident/CEOJuergen FroehlichChief Medical Officer
Nancy E PecotaVP:Finance/CFO
More Company Profile & Key Executives for AQGA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil